Literature DB >> 18652585

C-terminally truncated kindlin-1 leads to abnormal adhesion and migration of keratinocytes.

C Has1, R J Ludwig, C Herz, J S Kern, S Ussar, F R Ochsendorf, R Kaufmann, H Schumann, J Kohlhase, L Bruckner-Tuderman.   

Abstract

BACKGROUND: The Kindler syndrome (KS) protein kindlin-1 is a member of a protein complex that links cortical actin to integrins on the surface of basal keratinocytes. Loss of kindlin-1 leads to abnormalities of cell adhesion and motility, and to skin blistering and progressive poikiloderma as clinical symptoms.
OBJECTIVES: Here we investigated a severely affected patient, disclosed the mutation that caused the disease and delineated its biological consequences.
METHODS: Mutation screening of the kindlin-1 gene, KIND1 (now called FERMT1), was performed with polymerase chain reaction (PCR) amplification of all exons and sequencing. Mutated kindlin-1 was characterized by reverse transcriptase (RT)-PCR and immunoblotting, and genotype-phenotype correlations were analysed using immunohistochemical staining of skin biopsies and keratinocytes from the patient's skin. Cell adhesion and motility were assessed with functional tests.
RESULTS: We disclosed a splice site mutation in the first position of intron 13 of the FERMT1 gene, which caused skipping of exon 13. The short transcript partially escaped nonsense-mediated mRNA decay and was translated into a truncated protein.
CONCLUSION: A C-terminally truncated kindlin-1 in keratinocytes could not function correctly even if it were expressed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18652585     DOI: 10.1111/j.1365-2133.2008.08760.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  8 in total

Review 1.  [Kindler syndrome. A new bullous dermatosis].

Authors:  C Has
Journal:  Hautarzt       Date:  2009-08       Impact factor: 0.751

2.  FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.

Authors:  C-C Liu; D-L Cai; F Sun; Z-H Wu; B Yue; S-L Zhao; X-S Wu; M Zhang; X-W Zhu; Z-H Peng; D-W Yan
Journal:  Oncogene       Date:  2016-09-19       Impact factor: 9.867

3.  Kindlin-1 Is required for RhoGTPase-mediated lamellipodia formation in keratinocytes.

Authors:  Cristina Has; Corinna Herz; Elena Zimina; Hai-Yan Qu; Yinghong He; Zhi-Gang Zhang; Ting-Ting Wen; Yannick Gache; Monique Aumailley; Leena Bruckner-Tuderman
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

4.  Loss-of-function FERMT1 mutations in kindler syndrome implicate a role for fermitin family homolog-1 in integrin activation.

Authors:  Joey E Lai-Cheong; Maddy Parsons; Akio Tanaka; Siegfried Ussar; Andrew P South; Sethuraman Gomathy; John B Mee; Jean-Baptiste Barbaroux; Tanasit Techanukul; Noor Almaani; Suzanne E Clements; Ian R Hart; John A McGrath
Journal:  Am J Pathol       Date:  2009-09-17       Impact factor: 4.307

5.  Oxidative stress and mitochondrial dysfunction in Kindler syndrome.

Authors:  Elisabeth Zapatero-Solana; Jose Luis García-Giménez; Sara Guerrero-Aspizua; Marta García; Agustí Toll; Eulalia Baselga; Maria Durán-Moreno; Jelena Markovic; Jose Manuel García-Verdugo; Claudio J Conti; Cristina Has; Fernando Larcher; Federico V Pallardó; Marcela Del Rio
Journal:  Orphanet J Rare Dis       Date:  2014-12-21       Impact factor: 4.123

6.  FERMT1 contributes to the migration and invasion of nasopharyngeal carcinoma through epithelial-mesenchymal transition and cell cycle arrest.

Authors:  Lingling Li; Piao Li; Wei Zhang; Haiting Zhou; Ergang Guo; Guoqing Hu; Linli Zhang
Journal:  Cancer Cell Int       Date:  2022-02-10       Impact factor: 5.722

7.  Kindlin-1 regulates integrin dynamics and adhesion turnover.

Authors:  Coert Margadant; Maaike Kreft; Giovanna Zambruno; Arnoud Sonnenberg
Journal:  PLoS One       Date:  2013-06-11       Impact factor: 3.240

8.  Kindlin-1 Regulates Epidermal Growth Factor Receptor Signaling.

Authors:  Magdalene Michael; Rumena Begum; Grace K Chan; Austin J Whitewood; Daniel R Matthews; Benjamin T Goult; John A McGrath; Maddy Parsons
Journal:  J Invest Dermatol       Date:  2018-09-21       Impact factor: 8.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.